Browsing by Author "Redondo Sanchez, Andres"
Now showing items 1-6 of 6
-
A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors
Redondo Sanchez, Andres; Moura, David; Valverde Morales, Claudia Maria; Morales, Jose Manuel; Lopez Pousa, Antonio; Martin-Broto, Javier (Nature Research, 2022-10-21) -
Management of advanced ovarian cancer in Spain: an expert Delphi consensus
Redondo Sanchez, Andres; Oaknin Benzaquen, Ana Mazaltob; Rubio, Maria Jesus; Barretina-Ginesta, Maria-Pilar; de Juan Ferre, Ana; Manso, Luis (BMC, 2021-05-26) -
Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial
Grignani, Giovanni; Martínez-Trufero, Javier; Redondo Sanchez, Andres; Valverde Morales, Claudia Maria; Martin-Broto, Javier; Hindi, Nadia (BMJ Publishing Group, 2020-11) -
Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study
Poveda, Andres; Oaknin Benzaquen, Ana Mazaltob; Redondo Sanchez, Andres; Rubio, Maria Jesus; Guerra, Eva; Fariñas Madrid, Lorena; Rodriguez Freixinos, Victor; López-Reig, Raquel (MDPI, 2022-02-12) -
SEOM clinical guidelines for cervical cancer (2019)
de Juan Ferre, Ana; Redondo Sanchez, Andres; Rubio, Maria Jesus; García, Y.; Cueva, J.; Gaba, L.; Oaknin Benzaquen, Ana Mazaltob (Springer, 2020-02) -
Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS)
Pérez Fidalgo, José A; Ortega, Eugenia; Ponce Sebastia, Jordi; Redondo Sanchez, Andres; Sevilla, Isabel; Valverde Morales, Claudia Maria (SAGE Publications, 2023-03-28)